Home
Buy/Sell Shares
Indices
FTSE 100
Risers/Fallers
Sectors
News
RNS
Watchlist
Portfolio
Login / Register
Close
Company Search
Become a Member
Track your favourite stocks
Create & monitor portfolios
Daily portfolio value
Sign Up
Quickpicks
£
%
Company
Chg
Chg %
Add shares to your
quickpicks to
display them here!
Regulatory News
New Pharmacoeconomic Data on TYSABRI(R) Demonstrate Significant Reduction in Steroid Use and Hospitalizations in Patients with Multiple Sclerosis
New Pharmacoeconomic Data on TYSABRI(R) Demonstrate Significant Reduction in Steroid Use and Hospitalizations in Patients with Multiple Sclerosis
6th Oct 2006 14:07
a
Related Shares:
Eland Oil & Gas
FTSE 100 Latest
Value
8,275.66
Change
0.00